UNSPSC 51284021: Clomocycline sodium

This classification denotes a tetracycline antibiotic C23H24ClN2O9.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V4JNK46U1U, chemically known as 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-n-(hydroxymethyl)-6-methyl-1,11-dioxo-, monosodium salt, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-, but more generally known as clomocycline sodium, which bears US NIH Compound Identifier 72710627.

Most nations, for tariff and trade purposes, schedule clomocycline sodium under HS 29413000 and SITC 54133. As of Q4 2014, CLOMOCYCLINE SODIUM remains US FDA's Preferred Term for this commodity. SMILES: C[C@]1(C2C(CCC(C2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)[C@@H](C(=C(C4=O)C(=O)NCO)[O-])N(C)C)O)O)O)CL)O.[NA+].

UNSPSC 51284021 Clomocycline sodium is a Commodity code that does not align with recent state and local procurement activity. The four most recent opportunities posted under or near this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical and first aid supplies for fire departments, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing — none of which are clomocycline sodium or antibiotic agents. The code appears to see little relevant recent activity, and the posted opportunities suggest a tagging mismatch between the UNSPSC classification and the actual scope of work being solicited.

The issuing bodies in the recent record include a county health department (Seminole County, Florida), a state health and human services agency (Texas HHS Commission), a city fire department (Tampa Fire Department via City of Tampa), and a multi-state cooperative purchasing alliance (MMCAP). Geographic activity is concentrated in Florida, Texas, and Minnesota, with a cooperative purchasing arrangement extending to Oregon. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023); the City of Tampa's sheltered-market IFB for medical and first aid supplies at $700,000.00 (due March 13, 2026); Texas HHS's RFI on direct-to-manufacturer prescriptions (due April 3, 2026); and MMCAP's RFP for generic pharmaceuticals and OTC products (due March 26, 2026). None of these solicitations target clomocycline sodium or reflect the antibiotic pharmaceutical family this code nominally covers.